USA Secures Third Patent for Marine-Derived Antimicrobial Innovation

The University of San Agustin has secured its third patent, marking another significant milestone in its advancing research and innovation landscape.

Developed through the University’s Center for Chemical Biology and Biotechnology (C2B2) and Center for Natural Drug Discovery and Development (CND3), the patent covers an isolated Streptomyces strain and its antimicrobial compositions derived from marine sediment resources.

This achievement highlights USA’s continued pursuit of scientific discovery while promoting the responsible and sustainable use of natural resources. It reflects a strong and structured research pathway – from discovery and development to intellectual property protection and real-world application.

The innovation was supported by the University’s Innovation and Technology Support Office (ITSO), which plays a key role in advancing intellectual property protection and fostering a culture of innovation within the institution.

The research was led by a team of USA scientists: Doralyn S. Dalisay, Jonel P. Saludes, Chuckcris P. Tenebro, Carmela Vannette B. Vicera, Jovito Ysulat Jr., and Dana Joanne Von L. Trono, whose collaborative efforts made this breakthrough possible.

This milestone underscores the University of San Agustin’s commitment to strengthening research excellence and translating scientific discoveries into practical solutions that contribute to health, innovation, and sustainable development.

Viva San Agustin!